International Chair on Cardiometabolic Risk

CMR Short Reviews
- The Concept of CMR
  Historical background on global cardiometabolic risk, epidemiological aspects of obesity and type 2 diabetes, ABCs of cardiovascular disease risk factors, intra-abdominal adiposity, metabolic syndrome and contribution to cardiometabolic risk.
- Evaluating CMR
  Research and clinical tools to identify individuals with excess intra-abdominal adiposity and quantify their risk of diabetes and cardiovascular disease (global cardiometabolic risk).
- Managing CMR
  Notions and practical tools to better manage the abdominally obese patient with excess intra-abdominal adiposity and related clustering abnormalities.
Documentation Centre
- Slides, videos and more

Date	Categories	Title	Author	Format
February 05, 2010	Clinical Trials Hypertension	From the ONTARGET study results, does the method used to reduce blood pressure matter in terms of its impact on cardiovascular events?	Luis Miguel Ruilope, MD, Professor, Internal Medicine, Complutense University, Head of the Hypertension Unit, 12 de Octubre Hospital, Madrid, Spain	Expert Opinions Video 1:19 min. (7 MB)
July 10, 2009	Cardiovascular Disease Hypertension Metabolic Syndrome	What is the link between abdominal obesity and renal disease?	Luis Miguel Ruilope, MD, Professor, Internal Medicine, Complutense University, Head of the Hypertension Unit, 12 de Octubre Hospital, Madrid, Spain	Expert Opinions Video 1:13 min. (6 MB)
March 20, 2009	Hypertension Metabolic Syndrome	Could you comment on how the presence/absence of the metabolic syndrome affects the management of patients with hypertension?	Luis Miguel Ruilope, MD, Professor, Internal Medicine, Complutense University, Head of the Hypertension Unit, 12 de Octubre Hospital, Madrid, Spain	Expert Opinions Video 2:04 min. (7 MB)
January 30, 2009	Cardiovascular Disease Metabolic Syndrome	How do you see global CVD risk assessment in the future?	Luis Miguel Ruilope, MD, Professor, Internal Medicine, Complutense University, Head of the Hypertension Unit, 12 de Octubre Hospital, Madrid, Spain	Expert Opinions Video 2:18 min. (7 MB)
November 28, 2008	Hypertension Insulin Resistance Metabolic Syndrome	Could you comment on the fact that about 50% of hypertensive patients have insulin resistance whereas the other half do not show evidence of insulin resistance?	Luis Miguel Ruilope, MD, Professor, Internal Medicine, Complutense University, Head of the Hypertension Unit, 12 de Octubre Hospital, Madrid, Spain	Expert Opinions Video 1:01 min. (2 MB)
May 01, 2008	Cardiovascular Disease Hypertension	A simplified view of Victor Dzau´s cardiovascular continuum	Luis Miguel Ruilope, MD, Professor, Internal Medicine, Complutense University, Head of the Hypertension Unit, 12 de Octubre Hospital, Madrid, Spain	Slide Library 5 slides (0.3 MB)
September 06, 2007	Abdominal Obesity / Body Fat Distribution Hypertension Insulin Resistance	What is the link between visceral adiposity, insulin resistance, and hypertension?	Luis Miguel Ruilope, MD, Professor, Internal Medicine, Complutense University, Head of the Hypertension Unit, 12 de Octubre Hospital, Madrid, Spain	Expert Opinions Video 0:50 min. (3 MB)

The content of this website is provided for educational and informational purposes only and is not to be used for medical advice, diagnosis or treatment. Use of this site is subject to the terms and conditions contained in our Legal Notices.

Documentation Centre